Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Conaway

Showing results (121-130 of 127) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 127 results.
BMJ Open|June 6, 2022
Early empiric anti-<i>Mycobacterium tuberculosis</i> therapy for sepsis in sub-Saharan Africa: a protocol of a randomised clinical trialBibie Said, Edwin Nuwagira, Alphonce Liyoyo, et al.
Scientific Reports|May 29, 2025
Preterm birth increases susceptibility to hyperglycemia induced glomerular alterations in male miceAleksandra Cwiek, Rachel K Dailey, Ayyappa Kumar Sista Kameshwar, et al.
JAMA Network Open|January 28, 2026
Health Care-Associated Infections Among Neonates During the COVID-19 PandemicSagori Mukhopadhyay, Mark Conaway, Miren B Dhudasia, et al.
Proteomics. Clinical Applications|December 8, 2010
Clinical proteomics: A need to define the field and to begin to set adequate standardsHarald Mischak, Rolf Apweiler, Rosamonde E Banks, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 22, 2022
Pharmacokinetic-Pharmacodynamic Determinants of Clinical Outcomes for Rifampin-Resistant Tuberculosis: A Multisite Prospective Cohort StudyScott K Heysell, Stellah G Mpagama, Oleg B Ogarkov, et al.
Muscle & Nerve|May 26, 2016
International clinimetric evaluation of the MG-QOL15, resulting in slight revision and subsequent validation of the MG-QOL15rTed M Burns, Reza Sadjadi, Kimiaki Utsugisawa, et al.
The Lancet. Infectious Diseases|January 31, 2026
Immediate or high-dose antituberculosis therapy for HIV-related sepsis in Tanzania and Uganda (ATLAS): a phase 3, open-label, randomised, controlled, 2 × 2 factorial, superiority trialScott K Heysell, Stellah G Mpagama, Edwin Nuwagira, et al.
Pageof 13

Showing results (121-130 of 127) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 127 results.
BMJ Open|June 6, 2022
Early empiric anti-<i>Mycobacterium tuberculosis</i> therapy for sepsis in sub-Saharan Africa: a protocol of a randomised clinical trialBibie Said, Edwin Nuwagira, Alphonce Liyoyo, et al.
Scientific Reports|May 29, 2025
Preterm birth increases susceptibility to hyperglycemia induced glomerular alterations in male miceAleksandra Cwiek, Rachel K Dailey, Ayyappa Kumar Sista Kameshwar, et al.
JAMA Network Open|January 28, 2026
Health Care-Associated Infections Among Neonates During the COVID-19 PandemicSagori Mukhopadhyay, Mark Conaway, Miren B Dhudasia, et al.
Proteomics. Clinical Applications|December 8, 2010
Clinical proteomics: A need to define the field and to begin to set adequate standardsHarald Mischak, Rolf Apweiler, Rosamonde E Banks, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 22, 2022
Pharmacokinetic-Pharmacodynamic Determinants of Clinical Outcomes for Rifampin-Resistant Tuberculosis: A Multisite Prospective Cohort StudyScott K Heysell, Stellah G Mpagama, Oleg B Ogarkov, et al.
Muscle & Nerve|May 26, 2016
International clinimetric evaluation of the MG-QOL15, resulting in slight revision and subsequent validation of the MG-QOL15rTed M Burns, Reza Sadjadi, Kimiaki Utsugisawa, et al.
The Lancet. Infectious Diseases|January 31, 2026
Immediate or high-dose antituberculosis therapy for HIV-related sepsis in Tanzania and Uganda (ATLAS): a phase 3, open-label, randomised, controlled, 2 × 2 factorial, superiority trialScott K Heysell, Stellah G Mpagama, Edwin Nuwagira, et al.
Pageof 13